Total Payments
$9,152
2023 Payments
$37.08
Companies
46
Transactions
385
Medicare Patients
2,425
Medicare Billing
$691,234
Payment Breakdown by Category
Food & Beverage$7,067 (77.2%)
Consulting$1,050 (11.5%)
Travel$1,030 (11.3%)
Education$4.78 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,067 | 379 | 77.2% |
| Consulting Fee | $1,050 | 1 | 11.5% |
| Travel and Lodging | $1,030 | 4 | 11.3% |
| Education | $4.78 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,650 | 76 | $0 (2023) |
| Vertiflex, Inc. | $1,285 | 6 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $746.86 | 31 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $446.58 | 33 | $0 (2022) |
| Egalet US Inc | $418.35 | 40 | $0 (2018) |
| Avanos Medical | $311.39 | 8 | $0 (2020) |
| BioDelivery Sciences International, Inc. | $286.26 | 19 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $283.77 | 18 | $0 (2022) |
| Daiichi Sankyo Inc. | $232.75 | 14 | $0 (2019) |
| Purdue Pharma L.P. | $195.60 | 16 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $37.08 | 2 | Abbott Laboratories ($19.19) |
| 2022 | $1,053 | 49 | Abbott Laboratories ($442.14) |
| 2021 | $1,396 | 66 | BOSTON SCIENTIFIC CORPORATION ($338.92) |
| 2020 | $1,824 | 53 | Abbott Laboratories ($1,184) |
| 2019 | $1,121 | 59 | Abbott Laboratories ($238.52) |
| 2018 | $2,333 | 73 | Vertiflex, Inc. ($1,285) |
| 2017 | $1,389 | 83 | Abbott Laboratories ($422.03) |
All Payment Transactions
385 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/26/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Neuromodulation | ||||||
| 03/13/2023 | Innovation Technologies Inc | IRRISEPT (Device) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: JET LAVAGE DEVICE WITH CHG | ||||||
| 12/12/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: Neuromodulation | ||||||
| 12/08/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Neuromodulation | ||||||
| 12/08/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Neuromodulation | ||||||
| 11/17/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $167.86 | General |
| Category: Neuromodulation | ||||||
| 11/17/2022 | ACUMED LLC | ACUMED (Device) | Food and Beverage | In-kind items and services | $104.41 | General |
| Category: Foot & Ankle | ||||||
| 11/14/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: Neuromodulation | ||||||
| 11/14/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: Neuromodulation | ||||||
| 11/14/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $4.11 | General |
| Category: Neuromodulation | ||||||
| 09/28/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Gastroenterology | ||||||
| 09/22/2022 | Abbott Laboratories | PRODIGY (Device) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Neuromodulation | ||||||
| 09/21/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: Neuromodulation | ||||||
| 08/24/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Gastroenterology | ||||||
| 08/03/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.43 | General |
| Category: Opioid Analgesic | ||||||
| 07/27/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: PENNSAID | ||||||
| 07/25/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $8.09 | General |
| Category: Opioid Analgesic | ||||||
| 07/14/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.27 | General |
| Category: Opioid Analgesic | ||||||
| 07/07/2022 | Scilex Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $13.77 | General |
| 06/27/2022 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.62 | General |
| Category: Opioid Analgesic | ||||||
| 06/24/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: Neuromodulation | ||||||
| 06/22/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $35.20 | General |
| Category: Neuromodulation | ||||||
| 06/16/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $16.84 | General |
| Category: Pain Management | ||||||
| 06/13/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.36 | General |
| Category: Opioid Analgesic | ||||||
| 05/26/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 10 | 568 | 1,874 | $701,379 | $141,123 |
| 2021 | 20 | 937 | 2,604 | $1.7M | $284,640 |
| 2020 | 20 | 920 | 2,141 | $1.6M | $265,470 |
Total Patients
2,425
Total Services
6,619
Medicare Billing
$691,234
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 159 | 259 | $388,500 | $63,542 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 198 | 665 | $138,985 | $60,033 | 43.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 26 | 35 | $99,750 | $6,886 | 6.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 15 | 17 | $43,700 | $3,916 | 9.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 39 | $5,499 | $2,427 | 44.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $4,800 | $1,941 | 40.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 17 | 22 | $5,400 | $1,149 | 21.3% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2022 | 12 | 13 | $1,950 | $974.79 | 50.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 41 | 222 | $1,055 | $199.39 | 18.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 49 | 587 | $11,740 | $55.18 | 0.5% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 255 | 659 | $988,500 | $162,487 | 16.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 204 | 699 | $146,091 | $64,654 | 44.3% |
| 63650 | Implantation of spinal neurostimulator electrodes, accessed through the skin | Facility | 2021 | 14 | 38 | $151,430 | $9,425 | 6.2% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Office | 2021 | 29 | 35 | $99,750 | $7,053 | 7.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 50 | 50 | $10,500 | $3,850 | 36.7% |
| 27096 | Injection procedure into sacroiliac joint for anesthetic or steroid | Office | 2021 | 13 | 23 | $18,975 | $3,818 | 20.1% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Office | 2021 | 13 | 18 | $10,080 | $3,718 | 36.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $10,340 | $3,639 | 35.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance | Facility | 2021 | 13 | 17 | $12,920 | $2,961 | 22.9% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Office | 2021 | 11 | 12 | $22,800 | $2,940 | 12.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 50 | $7,050 | $2,752 | 39.0% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Facility | 2021 | 18 | 22 | $41,800 | $2,520 | 6.0% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2021 | 14 | 21 | $11,760 | $2,087 | 17.7% |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance, second level | Office | 2021 | 13 | 18 | $6,300 | $1,906 | 30.3% |
| 63685 | Insertion of spinal neurostimulator pulse generator or receiver | Facility | 2021 | 12 | 12 | $30,000 | $1,821 | 6.1% |
About Dr. Robert Moore, MD
Dr. Robert Moore, MD is a Interventional Pain Medicine healthcare provider based in The Woodlands, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245241124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Moore, MD has received a total of $9,152 in payments from pharmaceutical and medical device companies, with $37.08 received in 2023. These payments were reported across 385 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($7,067).
As a Medicare-enrolled provider, Moore has provided services to 2,425 Medicare beneficiaries, totaling 6,619 services with total Medicare billing of $691,234. Data is available for 3 years (2020–2022), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Anesthesiology, Pain Medicine
- Location The Woodlands, TX
- Active Since 08/10/2006
- Last Updated 07/27/2021
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1245241124
Products in Payments
- Superion ISS (Device) $1,285
- Axium Sheath Braided DRG (Device) $1,069
- XTAMPZA (Drug) $401.35
- PROCLAIM (Device) $374.54
- Superion (Device) $329.15
- RELISTOR (Drug) $267.81
- DRG IPGs (Device) $248.28
- ARYMO ER (Drug) $247.08
- Proclaim Family of SCS IPGs (Device) $232.76
- Proclaim IPG (Device) $189.05
- COOLIEF COOLED RADIOFREQUENCY (Device) $180.64
- SPRIX (Drug) $175.05
- LYRICA (Drug) $170.16
- SUPERION (Device) $150.03
- Neuromodulation Dspsbls and Accs (Device) $147.08
- Morphabond ER (Drug) $145.36
- BUNAVAIL 2.1 mg 30-count box (Drug) $143.74
- BELBUCA (Drug) $142.52
- Omnia (Device) $140.13
- Qutenza (Drug) $133.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.